Here are eight important observations:
1. The 2.3 percent-tax, which went into effect in 2013, has generated opposition from both Republicans and Democrats.
2. Its opponents claim that the tax kills jobs and stifles innovation.
2. Earlier this month, the House Ways and Means Committee voted to repeal the tax.
3. A Senate version of the repeal bill is also being developed, with five democrats co-sponsoring it.
4. Notably, Sen. Elizabeth Warren has supported killing the tax.
5. However, proponents of the tax claim that the PPACA has created customers for the medical device industry.
6. Additionally, the White House has stated that it will veto the Congress’ legislation because the tax pays for coverage provisions for millions of Americans.
7. Also, the House has not yet found a way to replace the approximately $24 billion in revenue that the tax would generate over the next decade or so.
8. The House will vote on the tax on Thursday, July 18. This will pressurize the Senate to schedule a vote on the tax soon.
More articles on devices:
InVivo Therapeutics updates board of directors — 5 key notes
Invuity begins NASDAQ trading, revises IPO close date — 5 key notes
5 key observations in orthobiologics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
